Form 4: TriSalus Life Sciences Executive Sells Shares
Insider Transaction (Form 4)
Jennifer Stevens, Chief Regulatory Officer of TriSalus Life Sciences, Inc., sold 316 shares of common stock on October 5, 2026 for $4.39 per share.
Summary
- Open-market sale: disposed of 316 Common Stock at $4.39 ($1,387) on October 5, 2026; holds 123,794 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $1,387 of stock on the open market.
Insider Transactions
Jennifer Stevens — Officer (Chief Regulatory Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-05 | Open-market sale | Common Stock | 316 | $4 | $1.4K | 123,794 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-05 | Open-market sale (316 shares) |
Keywords
insider transaction, Form 4, TLSI, TriSalus Life Sciences, Inc., bearish, Jennifer Stevens
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.